miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

Published:2011-05-09 Issue:43 Volume:30 Page:4386-4398
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Holleman A,Chung I,Olsen R R,Kwak B,Mizokami A,Saijo N,Parissenti A,Duan Z,Voest E E,Zetter B R

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2011148.pdf

Reference54 articles.

1. Anand S, Penrhyn-Lowe S, Venkitaraman AR . (2003). AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3: 51–62.

2. Aoki K, Taketo MM . (2007). Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci 120: 3327–3335.

3. Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, Dai Z et al. (2007). MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 6: 1483–1491.

4. Chu Q, Vincent M, Logan D, Mackay JA, Evans WK . (2005). Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline. Lung Cancer 50: 355–374.

5. Cleveland WS . (1979). Robust locally weighted regression and smoothing scatter plots. J Amer Statist Assoc 74: 829–836.

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bcl-2 Up-Regulation Mediates Taxane Resistance Downstream of APC Loss;International Journal of Molecular Sciences;2024-06-19

2. Updates in pharmacotherapy for non-small cell lung cancer: a focus on emerging tubulin inhibitors;Expert Opinion on Pharmacotherapy;2024-05-23

3. MyD88 signaling pathways: role in breast cancer;Frontiers in Oncology;2024-01-29

4. A review on the importance of miRNA-135 in human diseases;Frontiers in Genetics;2022-09-06

5. Clinical applications of noncoding RNAs in lung cancer patients;Clinical Applications of Non-Coding RNAs in Cancer;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3